CATALOG

Formula C16H24N2

Molar Mass 244.382 g·mol−1

Form: HCl Salt

IUPAC N-[2-(1H-indol-3-yl)]ethyl-N-propylpropan-1-amine

DPT or N,N-Dipropyltryptamine was first synthesized in the 1950’s. DPT is part of the tryptamine family and is structurally similar to N,N-DMT.

DPT is an analytical reference standard categorized as a tryptamine. This product is intended for research and forensic applications.

WARNING This product is not for human or veterinary use.

Formula C12H15BrN2

Molar Mass 267.170 g·mol−1

Form: Freebase

IUPAC [2-(5-Bromo-1H-indol-3-yl)ethyl]dimethylamine

5-Bromo-DMT or 5-bromo-N,N-dimethyltryptamine is a naturally occurring tryptamine. It is the 5-bromo derivative of DMT. 5-Bromo-DMT can be found in various sea sponges such as Smenospongia aurea and Smenospongia echina, as well as in Verongula rigida.

 5-Bromo-DMT is an analytical reference standard categorized as a tryptamine. This product is intended for research and forensic applications.

WARNING This product is not for human or veterinary use.

Formula C13H18N2O

Molar Mass 218.300 g·mol−1

IUPAC 3-{2-[Ethyl(methyl)amino]ethyl}-1H-indol-4-ol

Form: Fumarate

4-HO-MET or 4-Hydroxy-N-methyl-N-ethyltryptamine was first synthesized by Alexander Shulgin in the late 90’s. 4-HO-MET is a chemical of the tryptamine family, and it is the N-substituted ethyl homolog of 4-AcO-DMT.

For in-vitro research only, not for human or veterinary use. Handle with care and with the use of protective gloves.

Formula C25H33N3O2

Molar Mass 407.55 g·mol−1

IUPAC (8β)-1-pentanoyl-N,N-diethyl-6-methyl-9,10-didehydroergoline-8-carboxamide hemi-L-tartrate

Form: Hemi-L-Tartrate

1V-LSD or 1-Valeroyl-lysergic acid diethylamide is the newest lysergamide on the market. It was created and announced earlier this year by a research team in Europe. This new lysergamide was given the name “Valerie” for short. 1V-LSD holds similar properties to the rest of our catalogued lysergamides.

For in-vitro research only, not for human or veterinary use. Handle with care and with the use of protective gloves.

Formula C14H18N2O2

Molar Mass 246.310 g·mol−1

IUPAC 3-[2-(Dimethylamino)ethyl]-1H-indol-4-yl acetate

Form: Fumarate

First synthesized in 1963 by Albert Hofmann, 4-acetoxy-DMT also referred to as O-Acetylpsilocin is a semi-synthetic member of organic compounds of the tryptamine family.

For in-vitro research only, not for human or veterinary use. Handle with care and with the use of protective gloves.

Formula C17H26N2O

Molar Mass 274.408 g/mol−1

IUPAC 3-[2-(Diisopropylamino)ethyl]-5-methoxyindole

Form: HCl Salt

5-MeO-DiPT or 5-Methoxy-N,N-diisopropyltryptamine was first discovered in the mid 1970’s by Alexander Shulgin. 5-MeO-DiPT is the N-substituted diisopropyl homolog of 5-MeO-MiPT. Both share similar chemical structures and properties.

For in-vitro research only, not for human or veterinary use. Handle with care and with the use of protective gloves.

Formula C14H21NO3

Molar Mass 251.326 g/mol−1

IUPAC 2-{3,5-dimethoxy-4-[(2-methylprop-2-en-1-yl)oxy]phenyl}ethanamine

Form: Fumarate

Methallylescaline or 4-Methallyloxy-3,5-dimethoxyphenethylamine is a chemical of the phenethylamine family that was first synthesized by Alexander Shulgin. Methallylescaline also goes by “MAL” for short.

For in-vitro research only, not for human or veterinary use. Handle with care and with the use of protective gloves.

Formula C15H20N2O2

Molar Mass 260.337 g·mol−1

IUPAC 3-{2-[Ethyl(methyl)amino]ethyl}-1H-indol-4-yl acetate

Form: Fumarate

4-AcO-MET or 4-Acetoxy-N-methyl-N-ethyltryptamine is a chemical of the tryptamine family. 4-AcO-MET is an acetate ester analog of 4-HO-MET and the N-substituted ethyl homolog of 4-AcO-DMT.

For in-vitro research only, not for human or veterinary use. Handle with care and with the use of protective gloves.

Formula C24H31N3O2

Molar Mass 393.531 g·mol−1

IUPAC (6aR,9R)-4-butyryl-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carbox

Form: Hemi-L-Tartrate

1-Butanoyl-d-lysergic acid diethylamide or 1B-LSD is a novel lysergamide that has been available for research since 2018. 1B-LSD resembles the structures of other lysergamides such as 1CP-LSD, ALD-52, and 1P-LSD.

For in-vitro research only, not for human or veterinary use. Handle with care and with the use of protective gloves.

Formula C23H29N3O2

Molar Mass 379.504 g·mol−1

IUPAC (6aR,9R)-4-cyclopropionyl-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide

Form: Hemi-L-Tartrate

1-cyclopropionyl-lysergic acid diethylamide also named “Curie” by the original research group upon its discovery, however it is widely known as 1CP-LSD. This is a new novel lysergamide that has been available for research initially in 2019.  Any researchers looking for 1P-LSD can also use 1CP-LSD as a perfect substitute for your research, as it very closely resembles 1P-LSD, 1A-LSD and 1B-LSD.

For in-vitro research only, not for human or veterinary use. Handle with care and with the use of protective gloves.

Formula C23H29N3O2

Molar Mass 379.504 g·mol−1

IUPAC (6aR,9R)-N,N-Diethyl-7-methyl-4-propanoyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
Form: Hemi-L-Tartrate

1P-LSD is an analytical reference material categorized as a lysergamide. This product is intended for research and forensic applications.

1-propionyl-lysergic acid diethylamide or 1P-LSD for short has been available since 2015. As part of the family of lysergamides, 1P-LSD holds nearly identical properties to ALD-52, 1B-LSD and 1CP-LSD.

WARNING This product is not for human or veterinary use.

Formula C13H18N2O

Molar Mass 218.300 g·mol−1

IUPAC 2-(5-Methoxy-1H-indol-3-yl)-N,N-dimethylethanamine

Form: Freebase

5-Methoxy-N,N-dimethyltryptamine also known as 5-MEO DMT is a naturally occurring substance of the tryptamine class. 5-MEO-DMT was first synthesized in 1936. 5-MEO-DMT closely resembles the tryptamine derivative Bufotenine or 5-HO-DMT.
For in-vitro research only, not for human or veterinary use. Handle with care and with the use of protective gloves.

Formula C22H27N3O

Molar Mass 349.5 g·mol−1

IUPAC (6aR,9R)-N,N-diethyl-7-prop-2-enyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

Form: Hemi-L-Tartrate

6-Allyl-6-nor-lysergic acid diethylamide has been around since the late 80s. AL-LAD was only introduced to the market roughly around 2010. AL-LAD holds very similar properties to all our other lysergamides such as 1CP-LSD, ALD-52, and 1P-LSD and serves as a relatively good substitute for your research.

For in-vitro research only, not for human or veterinary use. Handle with care and with the use of protective gloves.

Formula C21H25N3O

Molar Mass 485.53 g·mol−1

IUPAC [(6aR,9R)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-yl]-[(2S,4S)-2,4-dimethylazetidin-1-yl]methanone

Form: Hemi-L-Tartrate

Lysergic acid 2,4-dimethylazetidide, also known as LSZ was developed in the early 2000’s by a team at Purdue University.  Just like the rest of our lysergamides LSZ also shares properties with  ALD-52, 1P-LSD , 1CP-LSD

For in-vitro research only, not for human or veterinary use. Handle with care and with the use of protective gloves.

Formula C15H22N2O

Molar Mass 218.29 g/mol−1

IUPAC N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amine HCl

Form: HCl Salt

5-MeO-MiPT or 5-Methoxy-N-methyl-N-isopropyltryptamine was first documented and synthesized by David Repke and Alexander Shulgin in 1985. 5-MeO-MiPT is also a member of the tryptamine family. It is the N-methyl-N-isopropyl homologue of 5-MeO-DMT and an analogue of 5-MeO-DiPT.

For in-vitro research only, not for human or veterinary use. Handle with care and with the use of protective gloves.